Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Increased risk of death in human immunodeficiency virus-infected children with pneumococcal meningitis in South Africa, 2003-2005.

Nyasulu P, Cohen C, De Gouveia L, Feldman C, Klugman KP, von Gottberg A; Group for Enteric, Respiratory and Meningeal Diseases Surveillance in South Africa (GERMS-SA).

Pediatr Infect Dis J. 2011 Dec;30(12):1075-80. doi: 10.1097/INF.0b013e31822cca05.

PMID:
21799459
2.

Effectiveness of 7-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in HIV-infected and -uninfected children in south africa: a matched case-control study.

Cohen C, von Mollendorf C, de Gouveia L, Naidoo N, Meiring S, Quan V, Nokeri V, Fortuin-de Smit M, Malope-Kgokong B, Moore D, Reubenson G, Moshe M, Madhi SA, Eley B, Hallbauer U, Kularatne R, Conklin L, O'Brien KL, Zell ER, Klugman K, Whitney CG, von Gottberg A; South African Invasive Pneumococcal Disease Case-Control Study Group.

Clin Infect Dis. 2014 Sep 15;59(6):808-18. doi: 10.1093/cid/ciu431. Epub 2014 Jun 9.

3.

Invasive pneumococcal disease in HIV seropositive children and adolescents.

Mattei SM, Falleiros-Carvalho LH, Cavalcante NJ.

J Pediatr (Rio J). 2008 May-Jun;84(3):276-80. doi: doi:10.2223/JPED.1762.

4.

Serotype 6C is associated with penicillin-susceptible meningeal infections in human immunodeficiency virus (HIV)-infected adults among invasive pneumococcal isolates previously identified as serotype 6A in South Africa.

du Plessis M, von Gottberg A, Madhi SA, Hattingh O, de Gouveia L, Klugman KP; Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa (GERMS-SA).

Int J Antimicrob Agents. 2008 Nov;32 Suppl 1:S66-70. doi: 10.1016/j.ijantimicag.2008.06.002. Epub 2008 Aug 23.

PMID:
18723328
5.

Risk factors for invasive pneumococcal disease among children less than 5 years of age in a high HIV prevalence setting, South Africa, 2010 to 2012.

von Mollendorf C, Cohen C, de Gouveia L, Naidoo N, Meiring S, Quan V, Lindani S, Moore DP, Reubenson G, Moshe M, Eley B, Hallbauer UM, Finlayson H, Madhi SA, Conklin L, Zell ER, Klugman KP, Whitney CG, von Gottberg A; South African IPD Case–Control Study Group.

Pediatr Infect Dis J. 2015 Jan;34(1):27-34. doi: 10.1097/INF.0000000000000484.

PMID:
24992122
6.

Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine.

Hsu K, Pelton S, Karumuri S, Heisey-Grove D, Klein J; Massachusetts Department of Public Health Epidemiologists.

Pediatr Infect Dis J. 2005 Jan;24(1):17-23.

PMID:
15665705
7.

Trends in mortality and antibiotic resistance among HIV-infected patients with invasive pneumococcal disease.

Grau I, Ardanuy C, Liñares J, Podzamczer D, Schulze MH, Pallares R.

HIV Med. 2009 Sep;10(8):488-95. doi: 10.1111/j.1468-1293.2009.00717.x. Epub 2009 May 6.

8.

Epidemiology of invasive pneumococcal infection in children aged five years and under in Saudi Arabia: a five-year retrospective surveillance study.

Memish ZA, El-Saed A, Al-Otaibi B, Shaalan MA, Alola SA, Thaqafi AO.

Int J Infect Dis. 2010 Aug;14(8):e708-12. doi: 10.1016/j.ijid.2010.02.2242.

9.

Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance.

Arifeen SE, Saha SK, Rahman S, Rahman KM, Rahman SM, Bari S, Naheed A, Mannan I, Seraji MH, Ahmed NU, Hassan MS, Huda N, Siddik AU, Quasem I, Islam M, Fatima K, Al-Emran H, Brooks WA, Baqui AH, Breiman RF, Sack D, Luby SP.

Clin Infect Dis. 2009 Mar 1;48 Suppl 2:S103-13. doi: 10.1086/596543.

PMID:
19191605
10.

Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009-2013.

von Mollendorf C, von Gottberg A, Tempia S, Meiring S, de Gouveia L, Quan V, Lengana S, Avenant T, du Plessis N, Eley B, Finlayson H, Reubenson G, Moshe M, O'Brien KL, Klugman KP, Whitney CG, Cohen C; Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa.

Clin Infect Dis. 2015 May 1;60(9):1346-56. doi: 10.1093/cid/civ059. Epub 2015 Feb 2.

PMID:
25645212
11.

Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.

Albrich WC, Baughman W, Schmotzer B, Farley MM.

Clin Infect Dis. 2007 Jun 15;44(12):1569-76. Epub 2007 May 8.

PMID:
17516400
12.

Invasive pneumococcal disease in HIV-infected adults: clinical changes after the introduction of the pneumococcal conjugate vaccine in children.

Burgos J, Peñaranda M, Payeras A, Villoslada A, Curran A, Garau M, Riera M, Crespo M, Navarro J, Van den Eynde E, Planes AM, Ribera E, Pahissa A, Falcó V.

J Acquir Immune Defic Syndr. 2012 Jan 1;59(1):31-8. doi: 10.1097/QAI.0b013e31823d0f5f.

PMID:
22156821
13.

[Pneumococcal meningitis in children in France: 832 cases from 2001 to 2007].

Levy C, Varon E, Bingen E, Picard C, de La Rocque F, Aujard Y, Cohen R; Groupe des pédiatres et microbiologistes de l'Observatoire National des Méningites.

Arch Pediatr. 2008 Dec;15 Suppl 3:S111-8. doi: 10.1016/S0929-693X(08)75493-9. French.

PMID:
19268240
14.

Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children.

Madhi SA, Petersen K, Madhi A, Wasas A, Klugman KP.

Pediatr Infect Dis J. 2000 Dec;19(12):1141-7.

PMID:
11144373
15.
16.

Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006.

Steenhoff AP, Wood SM, Rutstein RM, Wahl A, McGowan KL, Shah SS.

Pediatr Infect Dis J. 2008 Oct;27(10):886-91. doi: 10.1097/INF.0b013e3181734f8f.

PMID:
18776825
17.

[Pneumococcal meningitis mortality in children. Prognostic factors in a series of 73 cases].

Thabet F, Tilouche S, Tabarki B, Amri F, Guediche MN, Sfar MT, Harbi A, Yacoub M, Essoussi AS.

Arch Pediatr. 2007 Apr;14(4):334-7. Epub 2006 Dec 21. French.

PMID:
17187969
18.

Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users.

Harboe ZB, Larsen MV, Ladelund S, Kronborg G, Konradsen HB, Gerstoft J, Larsen CS, Pedersen C, Pedersen G, Obel N, Benfield T.

Clin Infect Dis. 2014 Oct 15;59(8):1168-76. doi: 10.1093/cid/ciu558. Epub 2014 Jul 17.

PMID:
25038114
19.

Epidemiology of invasive pneumococcal disease in the Arabian Peninsula and Egypt.

Shibl A, Memish Z, Pelton S.

Int J Antimicrob Agents. 2009 May;33(5):410.e1-9. doi: 10.1016/j.ijantimicag.2008.08.012. Epub 2008 Oct 30. Review.

PMID:
18976887
20.

Community-acquired bacteremia in human immunodeficiency virus-infected children in Harare, Zimbabwe.

Nathoo KJ, Chigonde S, Nhembe M, Ali MH, Mason PR.

Pediatr Infect Dis J. 1996 Dec;15(12):1092-7.

PMID:
8970218

Supplemental Content

Support Center